Literature DB >> 3107419

[Effect of Disoprivan (propofol) on the circulation and oxygen consumption of the brain and CO2 reactivity of brain vessels in the human].

H Stephan, H Sonntag, H D Schenk, S Kohlhausen.   

Abstract

The effects of Disoprivan on cerebral blood flow (CBF), cerebral oxygen consumption, and CO2-reactivity of the cerebral vessels were studied in 11 male patients between 49 and 63 years of age who were about to undergo coronary artery bypass surgery. Mean perfusion pressure was decreased by 25% under anaesthesia by 0.2 mg/kg per minute Disoprivan, but remained within the ranges of autoregulation. CBF decreased by 51% and cerebral vascular resistance (CVR) increased by 55% following a 36% decrease in cerebral oxygen consumption which was associated with a decrease in neuronal activity in the EEG. Hyperventilation led to a 25% further decrease in CBF due to a 43% increase in CVR while cerebral oxygen consumption remained unchanged. Hypoventilation was followed by a 67% increase in CBF and a 44% decrease in CVR cerebral oxygen consumption was decreased by 38%. This study shows that the reactivity of the cerebral vessels to changes in paCO2 is well maintained under Disoprivan.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107419

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  13 in total

Review 1.  Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.

Authors:  D M Steinbacher
Journal:  Anesth Prog       Date:  2001

Review 2.  General anaesthesia for supratentorial neurosurgery.

Authors:  P Ravussin; O Wilder-Smith
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Therapy of intracranial hypertension in patients with fulminant hepatic failure.

Authors:  Murugan Raghavan; Paul E Marik
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 4.  Changing practices in neuroanaesthesia.

Authors:  J C Drummond
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 5.  Propofol in patients with cardiac disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

6.  Infusion rate of propofol and jugular venous oxygen saturation.

Authors:  Yasunori Haranishi; Yasuhiro Kuroda; Yasutoshi Matayoshi; Hisashi Tamura; Hideo Oka; Kumiko Nakamura; Toru Gohara; Yoshiaki Nagusa; Kaori Yoshitomi
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

Review 7.  Propofol for sedation in neuro-intensive care.

Authors:  Michael P Hutchens; Stavros Memtsoudis; Nicholas Sadovnikoff
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 8.  Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.

Authors:  M S Langley; R C Heel
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  The effects of propofol and thiopental continuous infusion on serum potassium disturbances in neurosurgical patients.

Authors:  Tae Kyong Kim; Young-Jin Lim; Jae-Woo Ju; Jin Wook Kim; Hee-Pyoung Park
Journal:  J Korean Neurosurg Soc       Date:  2015-03-20

10.  A One-Day Prospective National Observational Study on Sedation-Analgesia of Patients with Brain Injury in French Intensive Care Units: The SEDA-BIP-ICU (Sedation-Analgesia in Brain Injury Patient in ICU) Study.

Authors:  Simon Poignant; Bernard Vigué; Patricia Balram; Mathieu Biais; Romain Carillon; Vincent Cottenceau; Claire Dahyot-Fizelier; Vincent Degos; Thomas Geeraerts; Patrick Jeanjean; Emmanuel Vega; Sigismond Lasocki; Fabien Espitalier; Marc Laffon
Journal:  Neurocrit Care       Date:  2021-07-30       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.